Altered mRNA expression of glycosyltransferases in human colorectal carcinomas and liver metastases.
about
The role of N-glycans in colorectal cancer progression: potential biomarkers and therapeutic applicationsIntra- and Extra-Cellular Events Related to Altered Glycosylation of MUC1 Promote Chronic Inflammation, Tumor Progression, Invasion, and MetastasisVerification of predicted alternatively spliced Wnt genes reveals two new splice variants (CTNNB1 and LRP5) and altered Axin-1 expression during tumour progression.Synthesis and expression of CDw75 antigen in human colorectal cancerEnhanced susceptibility of nasal polyp tissues to avian and human influenza virusesGlycosylation potential of human prostate cancer cell lines.alpha2,3-sialyltransferase ST3Gal III modulates pancreatic cancer cell motility and adhesion in vitro and enhances its metastatic potential in vivo.Down-regulation of Gal 3-O-sulfotransferase-2 (Gal3ST-2) expression in human colonic non-mucinous adenocarcinoma.ABH and Lewis histo-blood group antigens in cancer.The sweet and sour of serological glycoprotein tumor biomarker quantification.Transforming growth factor beta receptor 2 (TGFBR2) changes sialylation in the microsatellite unstable (MSI) Colorectal cancer cell line HCT116Emerging role of alpha2,6-sialic acid as a negative regulator of galectin binding and function.Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions.Aberrant glycosylation associated with enzymes as cancer biomarkers.Protein glycosylation in cancer.A Novel Function of CD82/KAI1 in Sialyl Lewis Antigen-Mediated Adhesion of Cancer Cells: Evidence for an Anti-Metastasis Effect by Down-Regulation of Sialyl Lewis Antigens.The engagement of selectins and their ligands in colorectal cancer liver metastases.ST6Gal-I modulates docetaxel sensitivity in human hepatocarcinoma cells via the p38 MAPK/caspase pathway.Aberrant glycosylation as biomarker for cancer: focus on CD43.Liver membrane proteome glycosylation changes in mice bearing an extra-hepatic tumor.Cell surface protein glycosylation in cancer.miR-125a-3p/FUT5-FUT6 axis mediates colorectal cancer cell proliferation, migration, invasion and pathological angiogenesis via PI3K-Akt pathway.Pre-metastatic niches: organ-specific homes for metastases.Silencing of ST6Gal I enhances colorectal cancer metastasis by down-regulating KAI1 via exosome-mediated exportation and thereby rescues integrin signaling.Identification of latent biomarkers in hepatocellular carcinoma by ultra-deep whole-transcriptome sequencing.Expression of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-12 in gastric and colonic cancer cell lines and in human colorectal cancer.Biosynthesis of the cancer-related sialyl-alpha 2,6-lactosaminyl epitope in colon cancer cell lines expressing beta-galactoside alpha 2,6-sialyltransferase under a constitutive promoter.Liver Galbeta1,4GlcNAc alpha2,6-sialyltransferase is down-regulated in human alcoholics: possible cause for the appearance of asialoconjugates.High expression of FUT3 is linked to poor prognosis in clear cell renal cell carcinoma.The expression pattern and histological distribution of sialyltransferases ST3Gal III in yellow chicken.Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene.Regulation of sialic acid O-acetylation in human colon mucosa.LncRNA HCP5 promotes follicular thyroid carcinoma progression via miRNAs sponge.Altered mRNA expressions of sialyltransferases in human gastric cancer tissues.Glycogene expression profiles based on microarray data from cervical carcinoma HeLa cells with partially silenced E6 and E7 HPV oncogenesAberrant O-glycosylation modulates aggressiveness in neuroblastoma
P2860
Q26779166-26C2DFC7-0120-42B4-B3BC-98D01F91398CQ28066445-EEB2151C-040F-44F1-AB2F-2DED31663FFFQ33246692-85EFE025-8CB9-4B6B-8597-AC944B3ABB81Q33517883-578F0429-E040-4C8D-8FEB-259EED66BEBAQ33707554-5A34BB04-9985-4E55-9FA7-D8AB51BB1990Q34046293-81DC04B0-E1C3-4F1B-8E8F-56EC418785ABQ34098948-EFED1514-39C6-4151-BB8C-1A775B5B7952Q34130747-D5343E90-756A-4FD1-BB54-4C9DBC05528EQ34215529-C7AB889F-D9D2-4C52-B8E2-53075FF8C43EQ34580285-1F7A5FF7-0725-4293-9494-59ADCE01E271Q34611732-6A9E8676-4183-413C-8371-703FEE7B67EAQ34676070-840382E0-6C07-4277-8411-9E98993DB23FQ34683362-497423A1-33CE-4D7D-9468-FFF49499A541Q35206309-D4AFFFF5-2C2E-4616-8B79-5D11E84D2674Q35413473-7C1F37F2-9009-4310-9BB2-FACB27B4F8E1Q35553436-933CE853-D376-44FB-9D1C-C49540B5E98CQ37559776-EBC9A1ED-9065-4060-82A1-6E6E98267567Q37588392-880BB404-5FA6-412E-AC88-8F3E71929DA2Q37618865-76532B0F-5CF2-428F-A747-321EB0369D80Q37694940-F639E4BF-E529-4B00-937D-78223D4A29B5Q38171440-8D4C4767-7DC3-4E8D-AE15-B84D379AF087Q38644655-99227217-22A1-43EC-9B21-BBC9E60A04AEQ38743711-98BDBF18-A53D-412F-A41D-55A32AF61200Q38750232-E6E75654-2A42-4EFF-A3B7-6935C83855C9Q39076259-7882A3B1-5854-42E3-B62D-81EB446F6BE9Q40489058-82FDB037-42C7-4E43-9AC6-5E8D44CE4F6CQ40766636-E91D4CD5-D6B9-4162-9918-958734F5C8DFQ41127356-175F2AE7-925F-4283-BA98-BE11C3660D23Q41775527-001E9997-7A5A-4298-B5A0-92A879F2C6CBQ42276866-7833285A-A23A-4BF2-BEE2-C50B2661AF50Q44482357-D234F57D-47DE-4AF4-8726-87B5360F91E4Q44854135-5DF499AE-694E-4946-B795-141D71F77D38Q52363986-5A3AAB2B-D755-4DF6-A1CC-3E8F52F9C3A6Q54398386-97EFE67E-CFCD-4A54-B4F3-FA44FA05F02DQ56889497-86F60817-8B0E-474F-A97A-11EE7E7EA2C1Q57821545-E84B30F2-69C8-487F-BD33-64BFAD8412E9
P2860
Altered mRNA expression of glycosyltransferases in human colorectal carcinomas and liver metastases.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Altered mRNA expression of gly ...... rcinomas and liver metastases.
@ast
Altered mRNA expression of gly ...... rcinomas and liver metastases.
@en
type
label
Altered mRNA expression of gly ...... rcinomas and liver metastases.
@ast
Altered mRNA expression of gly ...... rcinomas and liver metastases.
@en
prefLabel
Altered mRNA expression of gly ...... rcinomas and liver metastases.
@ast
Altered mRNA expression of gly ...... rcinomas and liver metastases.
@en
P2093
P2860
P356
P1433
P1476
Altered mRNA expression of gly ...... rcinomas and liver metastases.
@en
P2093
P2860
P304
P356
10.1136/GUT.46.3.359
P407
P577
2000-03-01T00:00:00Z